Elevance Health, Inc. (ELV) operating KPIs
ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3012% below fair value
$420.07−1.95 (-0.46%)
Close on Oct 30, 2026Market cap $91.10BP/E 18.7Yield –
Elevance Health adjusted Shareholders' Diluted EPS (Non-GAAP) ($)
Quarterly figures from Elevance Health's filings and investor materials
Latest, Q3 2026
6.99
Period ended Sep 30, 2026
Change on a year earlier
+15.9%
6.03 in Q3 2025
History
26 quarters
Since Q1 2020
Sources
18
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Adjusted Shareholders' Diluted EPS (Non-GAAP) ($) | Year on year | Source |
|---|---|---|---|---|
| Q3 2026 | Sep 30, 2026 | 6.99 | +15.9% | 8-K ER (FY2026Q3, 2026-10-21) ↗ |
| Q2 2026 | Jun 30, 2026 | 7.45 | -15.7% | 8-K ER (FY2026Q2, 2026-07-15) ↗ |
| Q1 2026 | Mar 31, 2026 | 12.58 | +5.1% | 8-K ER (FY2026Q1, 2026-04-22) ↗ |
| Q4 2025 | Dec 31, 2025 | 3.33 | +3.1% | 8-K ER (FY2025Q4, 2026-01-28) ↗ |
| Q3 2025 | Sep 30, 2025 | 6.03 | -29.9% | 8-K ER (FY2026Q3, 2026-10-21) ↗ |
| Q2 2025 | Jun 30, 2025 | 8.84 | -14.2% | 8-K ER (FY2026Q2, 2026-07-15) ↗ |
| Q1 2025 | Mar 31, 2025 | 11.97 | +10.5% | 8-K ER (FY2026Q1, 2026-04-22) ↗ |
| Q4 2024 | Dec 31, 2024 | 3.23 | -42.5% | 8-K ER (FY2025Q4, 2026-01-28) ↗ |
| Q3 2024 | Sep 30, 2024 | 8.60 | -4.3% | 8-K ER (FY2025Q3, 2025-10-21) ↗ |
| Q2 2024 | Jun 30, 2024 | 10.30 | +13.9% | 8-K ER (FY2025Q2, 2025-07-17) ↗ |
| Q1 2024 | Mar 31, 2024 | 10.83 | +14.5% | 8-K ER (FY2025Q1, 2025-04-22) ↗ |
| Q4 2023 | Dec 31, 2023 | 5.62 | +7.5% | 8-K ER (FY2024Q4, 2025-01-23) ↗ |
| Q3 2023 | Sep 30, 2023 | 8.99 | +19.4% | 8-K ER (FY2024Q3, 2024-10-17) ↗ |
| Q2 2023 | Jun 30, 2023 | 9.04 | +12.4% | 8-K ER (FY2024Q2, 2024-07-17) ↗ |
| Q1 2023 | Mar 31, 2023 | 9.46 | – | 8-K ER (FY2024Q1, 2024-04-18) ↗ |
| Q4 2022 | Dec 31, 2022 | 5.23 | +1.8% | 8-K ER (FY2022Q4, 2023-01-25) ↗ |
| Q3 2022 | Sep 30, 2022 | 7.53 | +10.9% | 8-K ER (FY2022Q3, 2022-10-19) ↗ |
| Q2 2022 | Jun 30, 2022 | 8.04 | +14.4% | 8-K ER (FY2022Q2, 2022-07-20) ↗ |
| Q4 2021 | Dec 31, 2021 | 5.14 | +102.4% | 8-K ER (FY2022Q4, 2023-01-25) ↗ |
| Q3 2021 | Sep 30, 2021 | 6.79 | +61.7% | 8-K ER (FY2022Q3, 2022-10-19) ↗ |
| Q2 2021 | Jun 30, 2021 | 7.03 | -23.6% | 8-K ER (FY2022Q2, 2022-07-20) ↗ |
| Q1 2021 | Mar 31, 2021 | 7.01 | +8.2% | 8-K ER (FY2021Q1, 2021-04-21) ↗ |
| Q4 2020 | Dec 31, 2020 | 2.54 | – | 8-K ER (FY2021Q4, 2022-01-26) ↗ |
| Q3 2020 | Sep 30, 2020 | 4.20 | – | 8-K ER (FY2021Q3, 2021-10-20) ↗ |
| Q2 2020 | Jun 30, 2020 | 9.20 | – | 8-K ER (FY2021Q2, 2021-07-21) ↗ |
| Q1 2020 | Mar 31, 2020 | 6.48 | – | 8-K ER (FY2021Q1, 2021-04-21) ↗ |
Cite this data
StockData. (2026). Elevance Health Adjusted Shareholders' Diluted EPS (Non-GAAP) ($), quarterly Q1 2020–Q3 2026 [Data set]. Compiled from Elevance Health SEC filings and investor materials. https://stockdatahq.com/stocks/elv/kpis/fin_adjusted_eps_diluted
See every metric in the Elevance Health KPI table. Data updated Oct 28, 2026.